Clivel Charlton to Parkinson Disease
This is a "connection" page, showing publications Clivel Charlton has written about Parkinson Disease.
Connection Strength
1.265
-
Mackey VR, Muthian G, Smith M, King J, Charlton CG. Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice. Life Sci. 2012 Nov 02; 91(19-20):921-7.
Score: 0.373
-
King JM, Muthian G, Mackey V, Smith M, Charlton C. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease. Life Sci. 2011 Oct 24; 89(17-18):638-43.
Score: 0.346
-
Muthian G, Mackey V, King J, Charlton CG. Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Neuroscience. 2010 Sep 01; 169(3):1085-93.
Score: 0.319
-
Charlton CG, Mack J. Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism. Mol Neurobiol. 1994 Aug-Dec; 9(1-3):149-61.
Score: 0.106
-
Benson R, Crowell B, Hill B, Doonquah K, Charlton C. The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance. Neurochem Res. 1993 Mar; 18(3):325-30.
Score: 0.096
-
Crowell BG, Benson R, Shockley D, Charlton CG. S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms. Behav Neural Biol. 1993 May; 59(3):186-93.
Score: 0.024